156 related articles for article (PubMed ID: 28031411)
21. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
[TBL] [Abstract][Full Text] [Related]
22. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
23. RUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells.
Barghout SH; Zepeda N; Vincent K; Azad AK; Xu Z; Yang C; Steed H; Postovit LM; Fu Y
Gynecol Oncol; 2015 Sep; 138(3):647-55. PubMed ID: 26186909
[TBL] [Abstract][Full Text] [Related]
24. In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.
Kodama M; Kodama T; Newberg JY; Katayama H; Kobayashi M; Hanash SM; Yoshihara K; Wei Z; Tien JC; Rangel R; Hashimoto K; Mabuchi S; Sawada K; Kimura T; Copeland NG; Jenkins NA
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7301-E7310. PubMed ID: 28811376
[TBL] [Abstract][Full Text] [Related]
25. Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells.
Pastò A; Pagotto A; Pilotto G; De Paoli A; De Salvo GL; Baldoni A; Nicoletto MO; Ricci F; Damia G; Bellio C; Indraccolo S; Amadori A
Oncotarget; 2017 Jan; 8(4):6433-6445. PubMed ID: 28031535
[TBL] [Abstract][Full Text] [Related]
26. Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems.
Patra B; Lateef MA; Brodeur MN; Fleury H; Carmona E; Péant B; Provencher D; Mes-Masson AM; Gervais T
PLoS One; 2020; 15(12):e0244549. PubMed ID: 33382759
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.
Fischer M; Müller GA
Crit Rev Biochem Mol Biol; 2017 Dec; 52(6):638-662. PubMed ID: 28799433
[TBL] [Abstract][Full Text] [Related]
28. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.
Chen MW; Yang ST; Chien MH; Hua KT; Wu CJ; Hsiao SM; Lin H; Hsiao M; Su JL; Wei LH
Cancer Res; 2017 Apr; 77(8):1955-1967. PubMed ID: 28209618
[TBL] [Abstract][Full Text] [Related]
29. Structural mechanisms of DREAM complex assembly and regulation.
Guiley KZ; Liban TJ; Felthousen JG; Ramanan P; Litovchick L; Rubin SM
Genes Dev; 2015 May; 29(9):961-74. PubMed ID: 25917549
[TBL] [Abstract][Full Text] [Related]
30. Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy.
Xing H; Wang S; Hu K; Tao W; Li J; Gao Q; Yang X; Weng D; Lu Y; Ma D
J Cancer Res Clin Oncol; 2005 Aug; 131(8):511-9. PubMed ID: 15924242
[TBL] [Abstract][Full Text] [Related]
31. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells.
Barghout SH; Zepeda N; Xu Z; Steed H; Lee CH; Fu Y
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):173-8. PubMed ID: 26522223
[TBL] [Abstract][Full Text] [Related]
32. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
Ma M; Yu N
Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
[TBL] [Abstract][Full Text] [Related]
33. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.
Puiffe ML; Le Page C; Filali-Mouhim A; Zietarska M; Ouellet V; Tonin PN; Chevrette M; Provencher DM; Mes-Masson AM
Neoplasia; 2007 Oct; 9(10):820-9. PubMed ID: 17971902
[TBL] [Abstract][Full Text] [Related]
34. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
36. ReN VM spheroids in matrix: A neural progenitor three-dimensional in vitro model reveals DYRK1A inhibitors as potential regulators of radio-sensitivity.
Wan X; Wu X; Hill MA; Ebner DV
Biochem Biophys Res Commun; 2020 Oct; 531(4):535-542. PubMed ID: 32807492
[TBL] [Abstract][Full Text] [Related]
37. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer.
Zhang W; Liu R; Tang C; Xi Q; Lu S; Chen W; Zhu L; Cheng J; Chen Y; Wang W; Zhong J; Deng Y
Int J Biol Macromol; 2016 Apr; 85():405-16. PubMed ID: 26772918
[TBL] [Abstract][Full Text] [Related]
38. Metformin and epithelial ovarian cancer therapeutics.
Patel S; Kumar L; Singh N
Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765
[TBL] [Abstract][Full Text] [Related]
39. Dynamic pattern of expression of dlin52, a member of the Myb/MuvB complex, during Drosophila development.
Bhaskar PK; Mukherjee A; Mutsuddi M
Gene Expr Patterns; 2012; 12(1-2):77-84. PubMed ID: 22178095
[TBL] [Abstract][Full Text] [Related]
40. Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissues.
Chen JL; Chen F; Zhang TT; Liu NF
Int J Mol Med; 2016 Jun; 37(6):1601-10. PubMed ID: 27081781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
